• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KZA 0.00% 8.0¢

KAZIA THERAPEUTICS LIMITED

Kazia Therapeutics Limited is an Australia-based oncology-focused drug development... Kazia Therapeutics Limited is an Australia-based oncology-focused drug development company. The Company is engaged in pharmaceutical research and development. The Company’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer. The Company’s lead programs include paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of VEGFR3. EVT801 is being developed in patients with advanced cancer. EVT801 targets angiogenesis, the formation of new blood vessels around a tumor.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
KZA
International Brokerage Accounts
29/02/24 14 3.3K
29/02/24 Last post  Metrader Comments Created with Sketch.  14  Views Created with Sketch.  3.3K 
KZA
KZIA - Banter and General Comments
2
22/02/24 82 24K
22/02/24 Last post  harvett Comments Created with Sketch.  82  Views Created with Sketch.  24K 
KZA
News: KZA Kazia Therapeutics Ltd Files For Shelf Of Up To 591,697 American Depositary Shares - SEC...
16/12/23 0 401
Metals & Mining SECTOR NEWS

Silvercorp provides OreCorp Offer update

ORR
04 Mar 2024
ORECORP LIMITED
16/12/23 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  401 
KZA 13/12/23 54 16K
13/12/23 Last post  Oupa Comments Created with Sketch.  54  Views Created with Sketch.  16K 
KZA
News: KZA Kazia Therapeutics Ltd- Announces $2 Million Registered Direct Offering
06/12/23 7 2.6K
06/12/23 Last post  rikki Comments Created with Sketch.  7  Views Created with Sketch.  2.6K 
KZA
Excellent interim DIPG data from PNOC
17/11/23 21 6.2K
17/11/23 Last post  Merchant2000 Comments Created with Sketch.  21  Views Created with Sketch.  6.2K 
KZA
Option 2 vs 3
2
15/11/23 71 18K
15/11/23 Last post  yolt Comments Created with Sketch.  71  Views Created with Sketch.  18K 
KZA 15/11/23 2 909
15/11/23 Last post  rikki Comments Created with Sketch.  2  Views Created with Sketch.  909 

See All Discussions arrow Created with Sketch.

Timeline

Removal from Official List
15 Nov 11:05
 
Change in substantial holding
14 Nov 08:18
 
Suspension from Official List
13 Nov 17:35
 
Change in substantial holding
08 Nov 08:23
 
Notice of Annual General Meeting/Proxy Form
03 Nov 08:59
 
Preliminary update from ongoing Phase 2 Study of Paxalisib
02 Nov 08:27
 
View More arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.